CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-12 | MEIER RICHARD A Director | Exercise or conversion | +8,500 | $67.81 | $576K | 117,494 |
| 2023-05-12 | MEIER RICHARD A Director | Shares withheld for taxes | −6,137 | $93.93 | $576K | 111,357 |
| 2023-05-12 | MEIER RICHARD A Director | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −8,500 | 0 | ||
| 2023-05-12 | HERON ELAINE J Director | Exercise or conversion | +8,500 | $67.81 | $576K | 94,068 |
| 2023-05-12 | HERON ELAINE J Director | Shares withheld for taxes | −6,137 | $93.93 | $576K | 87,931 |
| 2023-05-12 | HERON ELAINE J Director | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −8,500 | 0 | ||
| 2023-05-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +39,130 | $67.81 | $2.7M | 465,343 |
| 2023-05-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +7,370 | $67.81 | $500K | 472,713 |
| 2023-05-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Shares withheld for taxes | −6,337 | $93.93 | $595K | 466,376 |
| 2023-05-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Shares withheld for taxes | −33,644 | $93.93 | $3.2M | 432,732 |
| 2023-05-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −39,130 | 0 | ||
| 2023-05-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −7,370 | 0 | ||
| 2023-05-11 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion 10b5-1 | +30,000 | $67.81 | $2.0M | 456,213 |
| 2023-05-11 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale 10b5-1 | −24,439 | $94.55 | $2.3M | 431,774 |
| 2023-05-11 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale 10b5-1 | −5,561 | $95.22 | $530K | 426,213 |
| 2023-05-11 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 | −30,000 | 39,130 | ||
| 2023-05-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion 10b5-1 | +30,000 | $67.81 | $2.0M | 456,213 |
| 2023-05-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale 10b5-1 | −21,453 | $94.65 | $2.0M | 434,760 |
| 2023-05-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale 10b5-1 | −8,547 | $95.34 | $815K | 426,213 |
| 2023-05-09 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion 10b5-1 | +30,000 | $67.81 | $2.0M | 456,213 |
Page 14 of 23 · 450 trades